Growth Metrics

Korro Bio (KRRO) Income from Continuing Operations (2019 - 2025)

Korro Bio's Income from Continuing Operations history spans 7 years, with the latest figure at 67774000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations rose 418.8% year-over-year to 67774000.0, compared with a TTM value of 556000.0 through Dec 2025, up 100.66%, and an annual FY2025 reading of 556000.0, up 100.66% over the prior year.
  • Income from Continuing Operations for Q4 2025 was 67774000.0 at Korro Bio, up from 18061000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 67774000.0 in Q4 2025, with the low at 25770000.0 in Q2 2025.
  • Average Income from Continuing Operations over 5 years is 15348750.0, with a median of 20687000.0 recorded in 2021.
  • Year-over-year, Income from Continuing Operations crashed 511.02% in 2023 and then skyrocketed 418.8% in 2025.
  • Tracing KRRO's Income from Continuing Operations over 5 years: stood at 21500000.0 in 2021, then skyrocketed by 128.77% to 6186000.0 in 2022, then crashed by 511.02% to 25426000.0 in 2023, then increased by 16.39% to 21259000.0 in 2024, then skyrocketed by 418.8% to 67774000.0 in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Income from Continuing Operations are 67774000.0 (Q4 2025), 18061000.0 (Q3 2025), and 25770000.0 (Q2 2025).